Latest Insider Transactions at Treace Medical Concepts, Inc. (TMCI)
This section provides a real-time view of insider transactions for Treace Medical Concepts, Inc. (TMCI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TREACE MEDICAL CONCEPTS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TREACE MEDICAL CONCEPTS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
23,390
-53.16%
|
$374,240
$16.28 P/Share
|
|
Dec 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,710
-0.75%
|
$667,360
$16.29 P/Share
|
|
Dec 21
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
14,881
-12.99%
|
$238,096
$16.24 P/Share
|
|
Dec 21
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,584
-0.34%
|
$601,344
$16.23 P/Share
|
|
Dec 20
2021
|
James T Treace |
BUY
Other acquisition or disposition
|
Direct |
406,183
+21.75%
|
-
|
|
Dec 20
2021
|
James T Treace |
BUY
Other acquisition or disposition
|
Indirect |
406,183
+28.76%
|
-
|
|
Dec 20
2021
|
James T Treace |
SELL
Other acquisition or disposition
|
Indirect |
1,353,944
-49.08%
|
-
|
|
Dec 20
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
16,119
-0.56%
|
$241,785
$15.99 P/Share
|
|
Dec 20
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,911
-0.21%
|
$366,576
$16.03 P/Share
|
|
Dec 15
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
75,000
-3.32%
|
$1,200,000
$16.46 P/Share
|
|
Nov 24
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,000
-0.5%
|
$952,000
$17.83 P/Share
|
|
Nov 24
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
17,000
-1.18%
|
$289,000
$17.83 P/Share
|
|
Nov 23
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,000
-0.49%
|
$952,000
$17.69 P/Share
|
|
Nov 23
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
17,000
-0.58%
|
$289,000
$17.89 P/Share
|
|
Nov 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,000
-0.46%
|
$954,000
$18.73 P/Share
|
|
Nov 22
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
16,000
-0.54%
|
$288,000
$18.95 P/Share
|
|
Nov 17
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-1.16%
|
$500,000
$20.33 P/Share
|
|
Nov 16
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-1.15%
|
$500,000
$20.86 P/Share
|
|
Nov 15
2021
|
James T Treace |
SELL
Open market or private sale
|
Direct |
25,000
-0.57%
|
$500,000
$20.91 P/Share
|
|
Nov 12
2021
|
James T Treace |
SELL
Bona fide gift
|
Direct |
600,000
-34.68%
|
-
|
|
Nov 10
2021
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-99.12%
|
$525,000
$21.87 P/Share
|
|
Nov 10
2021
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.57 P/Share
|
|
Oct 27
2021
|
James T Treace |
SELL
Bona fide gift
|
Direct |
400,000
-9.87%
|
-
|
|
Oct 22
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
58,089
-0.5%
|
$1,161,780
$20.95 P/Share
|
|
Oct 21
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
76,084
-0.22%
|
$1,673,848
$22.25 P/Share
|
|
Oct 20
2021
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
11,171
-0.49%
|
$279,275
$25.18 P/Share
|
|
Oct 20
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,827
-0.26%
|
$770,675
$25.08 P/Share
|
|
Oct 06
2021
|
Joe W. Ferguson SVP, Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
308,641
+42.37%
|
$0
$0.1 P/Share
|
|
Sep 07
2021
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
560,000
-10.48%
|
-
|
|
Sep 07
2021
|
John T. Treace Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
408,816
+50.0%
|
-
|
|
Apr 27
2021
|
Daniel E. Owens |
BUY
Open market or private purchase
|
Direct |
4,000
+50.0%
|
$68,000
$17.0 P/Share
|
|
Apr 27
2021
|
F Barry Bays |
BUY
Conversion of derivative security
|
Direct |
413,326
+19.3%
|
-
|
|
Apr 27
2021
|
James T Treace |
BUY
Conversion of derivative security
|
Indirect |
569,067
+27.79%
|
-
|
|
Apr 27
2021
|
James T Treace |
BUY
Conversion of derivative security
|
Direct |
399,633
+15.34%
|
-
|
|
Apr 27
2021
|
Jaime A. Frias Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
329,230
-88.5%
|
$5,596,910
$17.0 P/Share
|
|
Apr 27
2021
|
Jaime A. Frias Chief Legal Officer |
BUY
Conversion of derivative security
|
Direct |
42,785
+10.31%
|
-
|
|
Apr 27
2021
|
Jaime A. Frias Chief Legal Officer |
BUY
Conversion of derivative security
|
Indirect |
85,570
+27.5%
|
-
|
|
Apr 27
2021
|
John K Bakewell |
BUY
Conversion of derivative security
|
Indirect |
342,300
+50.0%
|
-
|
|
Apr 27
2021
|
John R Treace Director |
SELL
Open market or private sale
|
Indirect |
401,250
-14.82%
|
$6,821,250
$17.0 P/Share
|
|
Apr 27
2021
|
John R Treace Director |
BUY
Conversion of derivative security
|
Indirect |
427,875
+13.65%
|
-
|
|
Apr 27
2021
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
3,600
+50.0%
|
$61,200
$17.0 P/Share
|
|
Apr 27
2021
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$170,000
$17.0 P/Share
|
|
Apr 27
2021
|
Richard W Mott |
BUY
Conversion of derivative security
|
Direct |
699,141
+29.17%
|
-
|
|
Apr 27
2021
|
Thomas E Timbie Director |
BUY
Conversion of derivative security
|
Indirect |
299,509
+9.6%
|
-
|
|
Apr 27
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,253,805
-47.03%
|
$89,314,685
$17.0 P/Share
|
|
Apr 27
2021
|
John T. Treace Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
299,510
+2.61%
|
-
|
|
Apr 27
2021
|
Joe W. Ferguson SVP, Research & Development |
BUY
Conversion of derivative security
|
Indirect |
85,575
+50.0%
|
-
|